A coalition of life sciences leaders and security experts urged the U.S. to require mandatory screening and recordkeeping for orders of synthetic nucleic acids. The open letter calls on lawmakers to codify guardrails covering synthetic DNA and the equipment needed for synthesis, citing AI-driven erosion of traditional barriers. The letter’s signatories include CEOs and representatives from major AI and biotech organizations, including Google DeepMind, OpenAI, Anthropic, Meta, Microsoft, Twist Bioscience, and Ansa Biotechnologies. From a biotech operations perspective, the request signals likely compliance expectations for synthesis vendors and downstream customers if policy moves from voluntary safeguards to mandated screening. Even without details on enforcement mechanics, the policy push frames synthetic DNA as a supply-chain choke point where standardization could become part of mainstream biotech governance.